451 related articles for article (PubMed ID: 26468100)
1. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
2. Candida albicans biofilms produce antifungal-tolerant persister cells.
LaFleur MD; Kumamoto CA; Lewis K
Antimicrob Agents Chemother; 2006 Nov; 50(11):3839-46. PubMed ID: 16923951
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm.
Sun J; Liu X; Jiang G; Qi Q
Antimicrob Agents Chemother; 2015 Mar; 59(3):1627-33. PubMed ID: 25547355
[TBL] [Abstract][Full Text] [Related]
4. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
5. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
Harrison JJ; Turner RJ; Ceri H
FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
[TBL] [Abstract][Full Text] [Related]
6. Candida albicans Amphotericin B-Tolerant Persister Formation is Closely Related to Surface Adhesion.
Sun J; Li Z; Chu H; Guo J; Jiang G; Qi Q
Mycopathologia; 2016 Feb; 181(1-2):41-9. PubMed ID: 26381156
[TBL] [Abstract][Full Text] [Related]
7. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
8.
Denega I; d'Enfert C; Bachellier-Bassi S
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783002
[No Abstract] [Full Text] [Related]
9. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
11. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
12. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
Braga PC; Culici M; Alfieri M; Dal Sasso M
Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
[TBL] [Abstract][Full Text] [Related]
13. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Perumal P; Mekala S; Chaffin WL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
15. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole.
Bink A; Vandenbosch D; Coenye T; Nelis H; Cammue BP; Thevissen K
Antimicrob Agents Chemother; 2011 Sep; 55(9):4033-7. PubMed ID: 21746956
[TBL] [Abstract][Full Text] [Related]
16. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
18. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
20. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
